Roman Butler Fullerton & Co. raised its stake in shares of Oracle Co. (NYSE:ORCL – Free Report) by 0.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,640 shares of the enterprise software provider’s stock after purchasing an additional 68 shares during the period. Roman Butler Fullerton & Co.’s holdings in Oracle were worth $2,549,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of ORCL. Janus Henderson Group PLC lifted its holdings in Oracle by 148.8% in the 1st quarter. Janus Henderson Group PLC now owns 12,872,300 shares of the enterprise software provider’s stock valued at $1,616,855,000 after purchasing an additional 7,699,141 shares in the last quarter. PineStone Asset Management Inc. raised its holdings in Oracle by 131.2% in the 2nd quarter. PineStone Asset Management Inc. now owns 3,911,201 shares of the enterprise software provider’s stock valued at $552,262,000 after acquiring an additional 2,219,450 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Oracle by 97.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 4,242,647 shares of the enterprise software provider’s stock worth $532,920,000 after purchasing an additional 2,093,893 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in shares of Oracle by 16,023.4% during the 3rd quarter. International Assets Investment Management LLC now owns 2,065,083 shares of the enterprise software provider’s stock worth $351,890,000 after purchasing an additional 2,052,275 shares during the last quarter. Finally, Altshuler Shaham Ltd increased its holdings in shares of Oracle by 5,853.1% in the second quarter. Altshuler Shaham Ltd now owns 1,552,580 shares of the enterprise software provider’s stock valued at $219,224,000 after purchasing an additional 1,526,500 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Stock Performance
NYSE:ORCL opened at $170.02 on Monday. The firm has a market cap of $471.14 billion, a price-to-earnings ratio of 43.82, a price-to-earnings-growth ratio of 3.09 and a beta of 1.02. The company has a debt-to-equity ratio of 6.68, a current ratio of 0.72 and a quick ratio of 0.72. Oracle Co. has a 1-year low of $99.26 and a 1-year high of $178.61. The firm’s fifty day moving average price is $163.43 and its 200 day moving average price is $142.24.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Thursday, October 10th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, October 10th. This represents a $1.60 annualized dividend and a yield of 0.94%. Oracle’s dividend payout ratio is presently 41.24%.
Insiders Place Their Bets
In other news, EVP Maria Smith sold 6,320 shares of the firm’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $165.00, for a total value of $1,042,800.00. Following the completion of the transaction, the executive vice president now owns 42,889 shares in the company, valued at $7,076,685. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 42.20% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. raised their price objective on shares of Oracle from $110.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday, September 9th. BMO Capital Markets boosted their price objective on shares of Oracle from $160.00 to $173.00 and gave the company a “market perform” rating in a report on Tuesday, September 10th. Citigroup upped their target price on shares of Oracle from $140.00 to $157.00 and gave the company a “neutral” rating in a research report on Wednesday, September 11th. DA Davidson upped their price objective on shares of Oracle from $105.00 to $140.00 and gave the stock a “neutral” rating in a report on Tuesday, September 10th. Finally, Melius Research raised Oracle from a “hold” rating to a “buy” rating in a research report on Monday, September 16th. Twelve equities research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $168.52.
Check Out Our Latest Research Report on Oracle
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading
- Five stocks we like better than Oracle
- What is the Nasdaq? Complete Overview with History
- November’s Small-Cap Treasures: 3 Stocks Poised for Growth
- How to Calculate Options Profits
- Bright Future for Clean Hydrogen Stocks? Analysts Are Watching
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- High-Yield AbbVie Gains Momentum: A 20% Upside Is in Sight
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.